The effect of milk polar lipids separated from butter serum on the lipid levels in the liver and the plasma of obese-model mouse (KK-Ay)

Journal of Functional Foods

Volumn 3, Issue 4, 2011, Pages 313-320

  Watanabe, Shiomi ^a   Takahashi, Tomoki ^a   Tanaka, Leo ^b   Haruta, Yuko ^b   Shiota, Makoto ^b   Hosokawa, Masashi ^a   Miyashita, Kazuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Ceramide; Lipid metabolism; Milk polar lipids; SCD1; Sphingomyelin

Indexed keywords

MUS;

EID: 80052264272     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.06.002     Document Type: Article

References (54)

1. AOAC, 2000. Official methods of analysis of AOAC international. 17th ed. Gaithersburg, MD, USA.
2. Astaire J.C., Ward R., German J.B., Jiménez-Flores R. Concentration of polar MFGM lipids from buttermilk by microfiltration and supercritical fluid extraction. Journal of Dairy Science 2003, 86:2297-2307.
3. Berra B., Colombo I., Sottocornola E., Giacosa A. Dietary sphingolipids in colorectal cancer prevention. European Journal of Cancer Prevention 2002, 11:193-197.
4. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959, 37:911-917.
5. Burgess J.W., Boucher J., Neville T.A.-M., Rouillard P., Stamler C., Zachariah S., et al. Phosphatidylinositol promotes cholesterol transport and excretion. Journal of Lipid Research 2003, 44:1355-1363.
6. Caboni M.F., Lercker G. Analysis of phospholipids in cow's milk by high-temperature injection gas chromatography and high-performance liquid chromatography. Journal of Chromatography 1984, 315:223-231.
7. Choi H.K., Willett W.C., Stampfer M.J., Rimm E., Hu F.B. Dairy consumption and risk of Type 2 diabetes mellitus in men. Archives of Internal Medicine 2005, 165:997-1003.
8. Dewettink K., Rombaut R., Thienpont N., Le T.T., Messens K., Camp J.V. Nutritional and technological aspects of milk fat globule membrane material. International Dairy Journal 2008, 18:436-457.
9. Dillehay D.L., Webb S.K., Schmelz E.-M., Merrill A.H. Dietary sphingomyelin inhibits 1, 2-dimethylhydrazine-induced colon cancer in CF1 mice. The Journal of Nutrition 1994, 124:615-620.
10. Duan R.-D. Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases. Scandinavian Journal of Gastroenterology 1998, 33:673-683.
11. Duan R.-D., Cheng Y., Hansen G., Hetervig E., Liu J.-J., Syk I., et al. Purification, localization, and expression of human intestinal alkaline sphingomyelinase. Journal of Lipid Research 2003, 44:1241-1250.
12. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric methods for determination of sugars and related substances. Analytical Chemistry 1956, 28:350-356.
13. Duivenvoorden I., Voshol P.J., Rensen P.C.N., van Duyvenvoorde W., Romijn J.A., Emeis J.J., et al. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice. The American Journal of Clinical Nutrition 2006, 84:312-321.
14. Eckhardt E.R.M., Wang D.Q.-H., Donovan J.M., Carey M.C. Dietary shingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002, 122:948-956.
15. Flowers M.T., Ntambi J.M. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Current Opinion in Lipidology 2008, 19:248-256.
16. Flowers M.T., Ntambi J.M. Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim Biophys Acta 2009, 1791:85-91.
17. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957, 226:497-509.
18. German J.B., Dillard C.A. Composition, structure and absorption of milk lipids: a source of energy, fat-soluble nutrients and bioactive molecules. Critical Reviews in Food Science and Nutrition 2006, 46:57-92.
19. German J.B., Gibson R.A., Krauss R.M., Nestel P., Lamarche B., van Staveren W.A., et al. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. European Journal of Nutrition 2009, 48:161-203.
20. Graves E.L.F., Beaulieu A.D., Drackley J.K. Factors affecting the concentration of sphingomyelin in bovine milk. Journal of Dairy Science 2007, 90:706-715.
21. Hinsch W., Ebersbach W.D., Sundaram P.V. Fully enzymic method of plasma triglyceride determination using an immobilized glycerol dehydrogenase nylon-tube reactor. Clinica Chimica Acta 1980, 104:95-100.
22. Horton B.S. Commercial utilization of minor milk components in the health and food industries. Journal of Dairy Science 1995, 78:2584-2589.
23. Jiang Y., Noh S.K., Koo S.I. Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats. The Journal of Nutrition 2001, 131:2358-2363.
24. Kivinen A., Tarpila S., Salminen S., Vapaatalo H. Gastroprotection with milk phospholipids: a first human study. Milchwissenschft 1992, 47:694-696.
25. Lopez C., Briad-Bion V., Menard O., Rousseau F., Pradel P., Besle J.-M. Phospholipid, sphingolipid, and fatty acid compositions of the milk fat globule membrane are modified by diet. Journal of Agricultural and Food Chemistry 2008, 56:5226-5236.
26. McDaniel M.A., Maier S.F., Einstein G.O. " Brain-specific" nutrients: amemory cure?. Nutrition 2003, 19:957-975.
27. Marshall R.T. Standard methods for the examination of dairy products 1992, The Am. Publ. Health Association, Inc., Washington D.C. 16th Ed.
28. Mente A., de Koning L., Shannon H.S., Anand S.S. A systematic review of the evidence supporting a casual link between dietary factors and coronary heart desease. Archives of Internal Medicine 2009, 169:659-669.
29. Miyazaki M., Kim Y.-C., Gray-Keller M.P., Attie A.D., Ntambi J.M. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. The Journal of Biological Chemistry 2000, 275:30132-30138.
30. Miyazaki M., Man W.C., Ntambi J.M. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. The Journal of Nutrition 2001, 131:2260-2268.
31. Noh S.K., Koo S.I. Egg sphingomyelin lowers the lymphatic absorption of cholesterol and α-tocopherol in rats. The Journal of Nutrition 2003, 133:3571-3576.
32. Ntambi J.M., Miyazaki M., Stoehr J.P., Lan H., Kendziorski C.M., Yandell B.S., et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11482-11486.
33. Ntambi J.M., Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Progress in Lipid Research 2004, 43:91-104.
34. Parodi P.W. Cows' milk fat components as potential anticarcinogenic agents. The Journal of Nutrition 1997, 127:1055-1060.
35. Parodi P.W. Symposium: a bold new look at milk fat. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk. Journal of Dairy Science 1999, 82:1339-1349.
36. Paton C.M., Ntambi J.M. Biochemical and physiological function of stearoyl-CoA desaturase. American Journal of Physiology: Endocrinology and Mmetabolism 2008, 297:E28-E37.
37. Pereira M.A., Jacobs D.R., van Horn L., Slattery M.L., Kartashov A.I., Ludwig D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults. The Journal of the American Medical Association 2002, 287:2081-2089.
38. Prevot A.F., Mordret F.X. Utilisation des colonnes capillaries de verre pour l'analyse des corps gras par chromotographie en phase gazeuse. Revue Francaise Des Corps Gras 1976, 23:409-423. (in French).
39. Rampone A.J., Long L.R. The effect of phosphatidylcholine and lysophosphatidylcholine on the absorption and mucosal metabolism of oleic acid and cholesterol in vitro. Biochim Biophys Acta 1977, 486:500-510.
40. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. The Journal of Nutrition 1993, 123:1939-1951.
41. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clinical Chemistry 1973, 19:1350-1356.
42. Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. The Journal of Biological Chemistry 2007, 282:2483-2493.
43. Sampath H., Ntambi J.M. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annual Review of Nutrition 2005, 25:317-340.
44. Samuelson G., Bratteby L.-E., Mohsen R., Vessby B. Dietary fat intake in healthy adolescents: inverse relationships between the estimated intake of saturated fatty acids and serum cholesterol. British Journal of Nutrition 2001, 85:333-341.
45. Schmelz E.M., Dillehay D.L., Webb S.K., Reiter A., Adams J., Merrill A.H. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1, 2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Research 1996, 56:4936-4941.
46. Schmelz E.M., Sullards M.C., Dillehay D.L., Merrill A.H. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. The Journal of Nutrition 2000, 130:522-527.
47. Séverin S., Wenshui X. Milk biologically active components as nutraceuticals:review. Critical Reviews in Food Science and Nutrition 2005, 45:645-656.
48. Sjogren S., Rosell M., Skoglund-Andersson C., Zdravkovic S., Vessby B., de Faire U., et al. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. The Journal of Nutrition 2004, 134:1729-1735.
49. Spitsberg V.L. Inivited review: bovine milk fat globule membrane as a potential nutraceuticals. Journal of Dairy Science 2005, 88:2289-2294.
50. Tholstrup T. Dairy products and cardiovascular disease. Current Opinion in Lipidology 2006, 17:1-10.
51. Thompson A.K., Singh H. Preparation of liposomes from milk fat globule membrane phospholipids using a microfluidizer. Journal of Dairy Science 2006, 89:410-419.
52. Van Hooijdonk A.C.M., Kussendrager K.D., Steijns J.M. In vivo antimicrobial and antiviral of components in bovine milk and colostrums involved in non-specific defence. British Journal of Nutrition 2000, 84:S127-S134.
53. Warensjö E., Jansson J.-H., Berglund L., Boman K., Ahrén B., Weinehall L., et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. British Journal of Nutrition 2004, 91:635-642.
54. Wat E., Tandy S., Kapera E., Kamili A., Chung R.W.S., Brown A., et al. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 2009, 205:144-150.